)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
ReproCELL Incorporated
ReproCELL Incorporated (4978) investor relations material
ReproCELL Incorporated Q1 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2027 earnings summary13 Aug, 2026
Executive summary
Net sales for the three months ended June 30, 2026, rose 14.9% year-over-year to ¥546 million, with operating loss at ¥310 million and ordinary loss at ¥149 million, both improving from the prior year.
Loss attributable to owners of parent was ¥149 million, a significant improvement from ¥304 million in the same period last year.
The company operates two main segments: Research Support Business (short- to medium-term earnings) and Medical Business (medium- to long-term growth), both leveraging iPS cell technology.
Financial highlights
Gross profit increased to ¥245 million from ¥194 million year-over-year.
Research Support Business net sales grew 10.3% to ¥483 million, with segment profit of ¥20 million versus a loss last year.
Medical Business net sales surged 69.2% to ¥63 million, with segment loss narrowing to ¥13 million from ¥58 million.
Basic earnings per share improved to ¥(1.56) from ¥(3.21) year-over-year.
Outlook and guidance
Full-year forecast for FY ending March 31, 2027, remains unchanged: net sales of ¥2,629 million (+17.7% YoY), operating loss of ¥630 million, and loss attributable to owners of parent of ¥458 million.
No dividend is planned for the fiscal year.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from ReproCELL Incorporated
- Sales and profits declined sharply, with losses deepening and forecasts revised downward.4978
Q3 2026 - Revenue declined 26% with deepening losses, but cash and equity remain strong.4978Q2 2026
- Revenue fell 23% and losses widened, but cash reserves and R&D investments remain robust.4978Q1 2026
- Revenue and net income increased, with strong growth in iPS and biotherapeutics segments.4978Q2 2025
- Revenue up 22.7% and net income positive, but losses expected next year as R&D ramps up.4978Q4 2025
- Revenue up 16.4% with narrowed losses; research support drives growth, medical profit falls.4978Q3 2025
Next ReproCELL Incorporated earnings date
Q2 202710 Nov, 2026
ReproCELL Incorporated
Next ReproCELL Incorporated earnings date
Q2 202710 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage